PE20010347A1 - Agonistas y antagonistas de estrogenos para indicaciones multiples - Google Patents

Agonistas y antagonistas de estrogenos para indicaciones multiples

Info

Publication number
PE20010347A1
PE20010347A1 PE2000000737A PE0007372000A PE20010347A1 PE 20010347 A1 PE20010347 A1 PE 20010347A1 PE 2000000737 A PE2000000737 A PE 2000000737A PE 0007372000 A PE0007372000 A PE 0007372000A PE 20010347 A1 PE20010347 A1 PE 20010347A1
Authority
PE
Peru
Prior art keywords
antagonists
estrogen agonists
multiple indications
phenyl
indications
Prior art date
Application number
PE2000000737A
Other languages
English (en)
Inventor
Li Julia Yu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20010347A1 publication Critical patent/PE20010347A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE AL USO DE MODULADORES SELECTIVOS DEL RECEPTOR DE ESTROGENO TAL COMO LASOFOXIFENO ((-)-CIS-6-FENIL-5-[4-(2-PIRROLIDIN-1-IL-ETOXI)-FENIL]-5,6,7,8-TERTRAHIDRONAFTALEN-2-OL); DROLOXIFENO PARA EL TRATAMIENTO DE LA OSTEOPOROSIS, ENFERMEDAD CARDIOVASCULAR, CANCER DE MAMA SIN INTERFERIR CON LA ACCION DE WARFARINA O PROPANOLOL
PE2000000737A 1999-07-28 2000-07-21 Agonistas y antagonistas de estrogenos para indicaciones multiples PE20010347A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14607299P 1999-07-28 1999-07-28
US14607599P 1999-07-28 1999-07-28

Publications (1)

Publication Number Publication Date
PE20010347A1 true PE20010347A1 (es) 2001-03-23

Family

ID=26843545

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000737A PE20010347A1 (es) 1999-07-28 2000-07-21 Agonistas y antagonistas de estrogenos para indicaciones multiples

Country Status (9)

Country Link
EP (1) EP1086692A3 (es)
JP (1) JP2001048805A (es)
KR (1) KR20010049909A (es)
AU (1) AU4882700A (es)
CA (1) CA2314572A1 (es)
HU (1) HUP0002979A2 (es)
IL (1) IL137428A0 (es)
NZ (1) NZ506014A (es)
PE (1) PE20010347A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436977B1 (en) * 1999-09-29 2002-08-20 Pfizer Inc. Dosing regimens for lasofoxifene
GB2475907A (en) * 2009-12-04 2011-06-08 Tcp Innovations Ltd Composition comprising a mixture of clopidogrel and droloxifene
US20190231743A1 (en) * 2016-10-11 2019-08-01 Sermonix Pharmaceuticals, Llc Lasofoxifene treatment of vva and osteoporosis in survivors of breast cancer and other malignancies
EP3525774B1 (en) 2016-10-11 2021-12-29 Duke University Lasofoxifene treatment of er+ breast cancer
CN117771239A (zh) 2018-04-10 2024-03-29 杜克大学 乳腺癌的拉索昔芬治疗
GB202116903D0 (en) 2021-11-18 2022-01-05 Sermonix Pharmaceuticals Inc Lasofoxifene treatment of aromatase-resistant er+ cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis

Also Published As

Publication number Publication date
NZ506014A (en) 2001-11-30
HUP0002979A2 (hu) 2002-04-29
KR20010049909A (ko) 2001-06-15
EP1086692A2 (en) 2001-03-28
EP1086692A3 (en) 2003-07-09
IL137428A0 (en) 2001-07-24
AU4882700A (en) 2001-02-01
CA2314572A1 (en) 2001-01-28
JP2001048805A (ja) 2001-02-20
HU0002979D0 (en) 2000-10-28

Similar Documents

Publication Publication Date Title
ES2172579T3 (es) Agonistas/antagonistas de estrogenos.
PA8548901A1 (es) Ligandos del receptor 5-ht y sus usos
ECSP077233A (es) Moduladores del receptor de progesterona que comprenden los derivados del pirrol-oxindol y los usos de los mismos
ECSP066773A (es) Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la síntesis de los mismos
UY26974A1 (es) Agonistas del receptor beta3 adrenérgico y usos de los mismos
AR028824A1 (es) Compuestos antagonistas npy-5 y su uso en la manufactura de medicamentos.
PA8638701A1 (es) Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
CL2015002098A1 (es) “compuestos derivados de benzotiofeno, antagonistas de receptores de estrógenos y degradantes selectivos de éstos (sreds); composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer de mamas, ovarios, endometrial, próstata, uterino, cervical y pulmones”. pct
UY28766A1 (es) Compuestos heteropolicíclicos adicionales y su uso como antagonistas del receptor de glutamato metabotrópico
ECSP003531A (es) Derivados de purina
ECSP003713A (es) Derivados de purina
ECSP034428A (es) Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso
ECSP066856A (es) Compuestos novedosos como moduladores del receptor opioide
UY27760A1 (es) Nuevos derivados de pirrolidinio.
HN1998000157A (es) Agonistas de prostaglandinas
UY28731A1 (es) Compuestos quimicos
MY155036A (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
ECSP088584A (es) Nuevos derivados de benzimidazol como inhibidores del receptor vanilloide 1 (vrl)
UY28870A1 (es) Derivados heterocíclicos, composiciones y proceso de preparación
EA200700367A1 (ru) Новые производные 4-бензилиденпиперидина
PE20010347A1 (es) Agonistas y antagonistas de estrogenos para indicaciones multiples
ECSP034860A (es) 5-sustituidas-2-arilpiridinas como moduladores del factor 1 de liberación de corticotropina
ECSP11011428A (es) Antagonistas del receptor tipo toll 3
PT1355639E (pt) Derivados de carboestirilo substituidos como agonistas do subtipo de receptores 5-ht1a
ECSP088603A (es) Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4

Legal Events

Date Code Title Description
FC Refusal